{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibwzfexinmpwpcejpr3rthab5jpqfoq2yynczggebu3msdacjdqaa",
    "uri": "at://did:plc:amgpmo7quvdl4rzvmmjibtx6/app.bsky.feed.post/3mlujn5x65nw2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihqnjj3cwxzh3i2e7hzh5k54ckdbyte6sjl5birq2u5yljap3xl44"
    },
    "mimeType": "image/jpeg",
    "size": 388071
  },
  "path": "/2026/05/14/us/politics/supreme-court-abortion-pill.html",
  "publishedAt": "2026-05-14T22:51:53.000Z",
  "site": "https://www.nytimes.com",
  "tags": [
    "Decisions and Verdicts",
    "Regulation and Deregulation of Industry",
    "Abortion",
    "United States Politics and Government",
    "Abortion Drugs",
    "Suits and Litigation (Civil)",
    "Drugs (Pharmaceuticals)",
    "Midterm Elections (2022)",
    "Telemedicine",
    "Federal Courts (US)",
    "Danco Laboratories",
    "Food and Drug Administration",
    "GenBioPro Inc",
    "Supreme Court (US)",
    "Duncan, Kyle (1972- )",
    "Trump, Donald J",
    "Louisiana",
    "Medicaid"
  ],
  "textContent": "A federal appeals court ruling against the Food and Drug Administration would have restricted access by mail to mifepristone.",
  "title": "Supreme Court Allows Abortion Pill Access by Mail to Continue"
}